ÂÜÀòÂÒÂ×

Dr. Bing Yan is Chief Medical Officer and Co-Founder at AnHeart Therapeutics. He was trained as a medical doctor and has more than 20 years of pharmaceutical industry experience in novel drug and vaccine development, regulatory interactions, and post-approval activities. Prior to joining AnHeart, Dr. Yan was the Global Vice-President and Head of Asia Pacific Clinical Research at Pfizer. He has deep experience across multiple therapeutic areas including neuroscience, vaccines, anti-infectives, transplant, oncology, men’s/women’s health, and metabolic disorders. He played a significant leadership role in bringing Prevnar13, Xalkori, Lyrica, Enbrel, Pristiq, Effexor, and Xyntha new drug registrations in China and Japan. Dr. Yan holds a doctorate in clinical medicine from Shanghai JiaoTong University Medical School/Ruijin Hospital and conducted his post-doc fellowship at Johns Hopkins University School of Medicine and Eastern Virginia Medical School.